Collaboration with international pharmaceutical company will also create life-science opportunities for Qatari students
A new partnership between Qatar Foundation (QF) and an international pharmaceutical company is aiming to advance precision medicine into mainstream clinical care in Qatar and open up opportunities for Qatari students to gain experience in the pharma industry.
Qatar Foundation Research, Development and Innovation (QF-RDI) and Roche have announced a three-year collaboration designed to help take more personalised, tailored treatments from the laboratory stage to the point where they are being used in primary healthcare settings, QF has said in a press statement.
By combining their expertise, QF-RDI and Roche will develop a repeatable process that translates the outcomes of precision medicine research into clinical use in Qatar, with the first stage focusing on how genetic markers can guide diagnoses and treatment decisions for diseases such as cancer. The two p